clopamide has been researched along with pituitrin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borbély, L; Radó, JP; Szám, I; Szigeti, L; Takó, J | 1 |
| Bános, C; Borbély, L; Radó, JP; Szende, L; Takó, J | 1 |
| Marosi, J; Radó, JP; Takó, J | 1 |
| Radó, JP; Szende, L | 1 |
1 trial(s) available for clopamide and pituitrin
| Article | Year |
|---|---|
Clinico-pharmacological investigations with chlorpropamide in diabetes insipidus associated with diabetes mellitus.
Topics: Carbutamide; Chlorpropamide; Clinical Trials as Topic; Clopamide; Craniocerebral Trauma; Diabetes Complications; Diabetes Insipidus; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Male; Middle Aged; Vasopressins | 1970 |
3 other study(ies) available for clopamide and pituitrin
| Article | Year |
|---|---|
Paradoxical increase in renal concentrating operation in response to furosemide during hypertonic saline infusion in man.
Topics: Clopamide; Diuretics; Drug Synergism; Female; Furosemide; Humans; Hypertonic Solutions; Infusions, Parenteral; Kidney Concentrating Ability; Kidney Function Tests; Kidney Tubules; Lysine; Male; Sodium Chloride; Stimulation, Chemical; Vasopressins | 1969 |
Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and
Topics: Clopamide; Diabetes Insipidus; Diuresis; Female; Furosemide; Humans; Hypertonic Solutions; Kidney Concentrating Ability; Lysine; Middle Aged; Sodium Chloride; Vasopressins | 1970 |
Use of hypertonic saline, clopamide and furosemide for evaluation of the concentrating defect in pitressin-treated diabetes insipidus.
Topics: Amides; Clopamide; Diabetes Insipidus; Diuretics; Female; Furosemide; Humans; Hypertonic Solutions; Kidney; Kidney Concentrating Ability; Kidney Diseases; Male; Middle Aged; Piperidines; Sodium Chloride; Tannins; Vasopressins | 1968 |